BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 19180897)

  • 21. Bullous subacute cutaneous lupus erythematosus.
    Perera GK; Black MM; McGibbon DH
    Clin Exp Dermatol; 2004 May; 29(3):265-7. PubMed ID: 15115507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nail changes secondary to docetaxel (Taxotere).
    Correia O; Azevedo C; Pinto Ferreira E; Braga Cruz F; Polónia J
    Dermatology; 1999; 198(3):288-90. PubMed ID: 10393455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nail disorders in a woman treated with ixabepilone for metastatic breast cancer.
    Alimonti A; Nardoni C; Papaldo P; Ferretti G; Caleno MP; Carlini P; Fabi A; Rasio D; Vecchione A; Cognetti F
    Anticancer Res; 2005; 25(5):3531-2. PubMed ID: 16101175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed seizure associated with paclitaxel-Cremophor el in a patient with early-stage breast cancer.
    O'Connor TL; Kossoff E
    Pharmacotherapy; 2009 Aug; 29(8):993-6. PubMed ID: 19637953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of weekly paclitaxel for advanced or metastatic breast cancer in Japan.
    Horiguchi J; Rai Y; Tamura K; Taki T; Hisamatsu K; Ito Y; Seriu T; Tajima T
    Anticancer Res; 2009 Feb; 29(2):625-30. PubMed ID: 19331212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paclitaxel-induced nail changes: possible role of its vehicle (Cremophor EL).
    Minutilli E; Izzo F; Natoli G; Psaila A; Di Filippo F; Terzoli E
    Eur J Dermatol; 2006; 16(6):693-4. PubMed ID: 17229616
    [No Abstract]   [Full Text] [Related]  

  • 27. Paclitaxel-induced neutrophilic adverse reaction and acral erythema.
    Cruz A; Temu T; Hines-Telang G; Kroumpouzos G
    Acta Derm Venereol; 2011 Jan; 91(1):86-7. PubMed ID: 21031283
    [No Abstract]   [Full Text] [Related]  

  • 28. Paclitaxel-induced acral erythema.
    Richards KN; Ivan D; Rashid RM; Chon SY
    Arch Dermatol; 2012 Nov; 148(11):1333-4. PubMed ID: 23165853
    [No Abstract]   [Full Text] [Related]  

  • 29. Paclitaxel-induced "recall" soft tissue ulcerations occurring at the site of previous subcutaneous administration of paclitaxel in low doses.
    du Bois A; Kommoss FG; Pfisterer J; Lück HJ; Meerpohl HG
    Gynecol Oncol; 1996 Jan; 60(1):94-6. PubMed ID: 8557235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffuse scleroderma occurring after the use of paclitaxel for ovarian cancer.
    De Angelis R; Bugatti L; Cerioni A; Del Medico P; Filosa G
    Clin Rheumatol; 2003 Feb; 22(1):49-52. PubMed ID: 12605319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug eruption due to Bufferin showing erythema exsudativum multiforme with a photo-recall-like phenomenon.
    Lee SG; Matsuyoshi N; Ohta K; Horiguchi Y; Imamura S
    Eur J Dermatol; 1998 Jun; 8(4):280-2. PubMed ID: 9649658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Docetaxel-induced Scleroderma in A Breast Cancer Patient: A Case Report.
    Kılıç MÖ; Yalaza M; Bilgiç Cİ; Dener C
    J Breast Health; 2015 Apr; 11(2):95-97. PubMed ID: 28331700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe dermatologic reactions at multiple sites after paclitaxel administration.
    Beri R; Rosen FR; Pacini MJ; Desai SR
    Ann Pharmacother; 2004 Feb; 38(2):238-41. PubMed ID: 14742758
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limited cutaneous systemic sclerosis induced by paclitaxel in a patient with breast cancer.
    Kawakami T; Tsutsumi Y; Soma Y
    Arch Dermatol; 2009 Jan; 145(1):97-8. PubMed ID: 19153362
    [No Abstract]   [Full Text] [Related]  

  • 35. Association between paclitaxel and necrotic pancreatitis.
    McMahon MA; Kearns G; McCaffrey J; Grogan L
    Ir Med J; 2006 Oct; 99(9):281. PubMed ID: 17144240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-induced, photosensitive, erythema multiforme-like eruption: possible role for cell adhesion molecules in a flare induced by Rhus dermatitis.
    Shiohara T; Chiba M; Tanaka Y; Nagashima M
    J Am Acad Dermatol; 1990 Apr; 22(4):647-50. PubMed ID: 1969427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypersensitivity reactions in paclitaxel treatment of ovarian cancer patients.
    Lehoczky O; Bagaméri A; Udvary J; Pulay T
    J Obstet Gynaecol; 2002 May; 22(3):312-3. PubMed ID: 12521509
    [No Abstract]   [Full Text] [Related]  

  • 38. [Safety evaluation of paclitaxel injection NK in adjuvant therapy for breast cancer].
    Takahara S; Yamamoto H; Tokushima Y; Shiba E
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1851-6. PubMed ID: 19920387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Taxol reactions.
    Price KS; Castells MC
    Allergy Asthma Proc; 2002; 23(3):205-8. PubMed ID: 12125509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Onycholysis associated with paclitaxel.
    Mackay-Wiggan J; Nair KG; Halasz CL
    Cutis; 2003 Mar; 71(3):229-32. PubMed ID: 12661751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.